Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China flag China · Delayed Price · Currency is CNY
22.74
-0.03 (-0.13%)
Feb 3, 2026, 1:05 PM CST

SHE:002262 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
23,12924,74427,32624,73615,76916,092
Market Cap Growth
-3.23%-9.45%10.47%56.87%-2.01%35.74%
Enterprise Value
19,18120,98423,97221,95613,32213,929
Last Close Price
22.7723.9626.3323.6714.8515.06
PE Ratio
18.8121.6426.3527.4619.7722.08
Forward PE
18.3618.5922.4124.3117.5818.30
PS Ratio
3.844.345.425.764.014.79
PB Ratio
2.863.404.264.433.223.92
P/TBV Ratio
2.943.504.384.493.274.00
P/FCF Ratio
45.0953.0943.0846.3931.8616.43
P/OCF Ratio
25.2527.0127.1028.7322.4912.89
PEG Ratio
1.411.091.021.351.660.87
EV/Sales Ratio
3.183.684.765.113.394.14
EV/EBITDA Ratio
13.0415.3819.9021.4313.8815.86
EV/EBIT Ratio
15.0217.3022.4124.3515.7217.82
EV/FCF Ratio
37.3945.0237.7941.1726.9114.22
Debt / Equity Ratio
0.010.010.020.020.020.01
Debt / EBITDA Ratio
0.030.050.090.090.110.04
Debt / FCF Ratio
0.090.150.180.170.220.04
Asset Turnover
0.700.720.730.710.750.75
Inventory Turnover
1.982.402.091.571.802.16
Quick Ratio
6.245.005.644.885.014.99
Current Ratio
7.295.686.465.865.935.77
Return on Equity (ROE)
16.19%16.67%17.25%16.78%17.72%18.86%
Return on Assets (ROA)
9.28%9.62%9.68%9.25%10.14%10.91%
Return on Invested Capital (ROIC)
27.80%32.44%33.10%31.80%34.72%37.47%
Return on Capital Employed (ROCE)
15.60%16.50%16.40%15.90%16.90%18.70%
Earnings Yield
5.32%4.62%3.79%3.64%5.06%4.53%
FCF Yield
2.22%1.88%2.32%2.16%3.14%6.09%
Dividend Yield
1.52%1.50%1.21%0.84%1.35%0.66%
Payout Ratio
29.81%28.31%19.54%22.51%12.63%13.98%
Buyback Yield / Dilution
-0.61%-0.53%0.53%-0.22%0.24%-0.72%
Total Shareholder Return
0.92%0.98%1.74%0.63%1.58%-0.06%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.